The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer

por Diaz, R, Nguewa, P A, Diaz-Gonzalez, J A, Hamel, E, Gonzalez-Moreno, O, Catena, R, Serrano, D, Redrado, M, Sherris, D, Calvo, A
Publicado 2009